{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:14:02Z","timestamp":1777493642741,"version":"3.51.4"},"reference-count":52,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Antipsychotic use among youth is common and is associated with metabolic side effects such as weight gain. Guidelines recommend periodic screening of metabolic measures in youth prescribed antipsychotics; however, a guideline-to-practice gap exists. We systematically reviewed the literature to synthesize the knowledge from interventions that aim to improve antipsychotic metabolic screening. We described the interventions' effect on screening rates, the strategies used for improvement, and study quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a systematic review of studies that attempted to improve antipsychotic metabolic risk screening practices among pediatric populations published between 2004 and August 2019. We included studies with an improvement intervention that compared screening rates before and after the intervention. We extracted data about study characteristics, screening rates in pre- and postintervention groups, strategies used to influence screening practices, and assessed studies' risk of bias. This review was prospectively registered with PROSPERO #CRD42018088241.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We identified six studies that demonstrated modest improvements in median metabolic screening rates for waist circumference (0%\u201316%), glucose (9%\u201339%), and lipids (11%\u201337%). Median postintervention screening rates were higher for weight and blood pressure (84% and 72.5%) compared with glucose and lipids (39% and 37%). Interventions used a variety of improvement strategies to address patient-, provider-, and organization-level barriers for screening, including increasing patient and provider knowledge regarding antipsychotic side effects, fostering social clinical environments that promote screening, and organizational commitment for screening antipsychotic-treated youth. All interventions were deemed at high risk of bias due to uncontrolled design and lack of adjustment for confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Included studies reported partial success in improving antipsychotic screening rates but were of poor methodological quality. Common improvement strategies may affect provider behavior to conduct metabolic screening, but these need to be tailored to local resources and organization structure. Future studies need to use rigorous methodology and theory-informed improvement strategies aligned with organizational actions to prioritize safe and judicious practice of antipsychotics among pediatric populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2020.0115","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T09:51:45Z","timestamp":1611913905000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Interventions to Improve Metabolic Risk Screening Among Children and Adolescents on Antipsychotic Medication: A Systematic Review"],"prefix":"10.1177","volume":"31","author":[{"given":"Osnat C.","family":"Melamed","sequence":"first","affiliation":[{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada."},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura R.","family":"LaChance","sequence":"additional","affiliation":[{"name":"St. Mary's Hospital, Montreal, Quebec, Canada."},{"name":"Department of Psychiatry, McGill University, Montreal, Quebec, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braden G.","family":"O'Neill","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada."},{"name":"North York General Hospital, Toronto, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"Rodak","sequence":"additional","affiliation":[{"name":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie H.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2082"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0016-6"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.596"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-017-0605-9"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12539"},{"key":"e_1_3_3_7_1","unstructured":"Carpenter LM: Toolkit to Improve Provider Adherence to Metabolic Monitoring of Atypical Antipsychotics for Youths. The University of North Carolina at Chapel Hill 2018."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.002762012"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1095"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10597-015-9833-0"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0034"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1207\/s15430421tip3903_2"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2016.0064"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.5.w770"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/DCC.0000000000000253"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2010.09.011"},{"key":"e_1_3_3_17_1","first-page":"679","article-title":"Metabolic monitoring in commercially insured pediatric patients newly initiated to take a second-generation antipsychotic","volume":"168","author":"Delate T","year":"2014","unstructured":"Delate T, , Kauffman YS, , Botts SR, , Wong C, , Gaughan KM: Metabolic monitoring in commercially insured pediatric patients newly initiated to take a second-generation antipsychotic. J Am Med Assoc Pediatr, 168:679\u2013681, 2014.","journal-title":"J Am Med Assoc Pediatr"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2015.21.9.769"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078390317752444"},{"key":"e_1_3_3_20_1","unstructured":"Findling R Drury S Jensen P Rapoport J Bukstein O Walter H Hamilton J: Practice parameter for the use of atypical antipsychotic medications in children and adolescents. Available at: https:\/\/www.aacap.org\/App_Themes\/AACAP\/docs\/practice_parameters\/Atypical_Antipsychotic_Medications_Web.pdf. Accessed January9 2021."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2010.04.018"},{"key":"e_1_3_3_22_1","unstructured":"Higgins JP Green S: Cochrane Handbook for Systematic Reviews of Interventions (Vol. 4). Chichester UK:. John Wiley & Sons 2011."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13034-017-0192-1"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2014.05.009"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39372.540903.94"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2019.04.022"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-013-0399-5"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201500553"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900108"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpediatrics.2010.48"},{"key":"e_1_3_3_32_1","first-page":"96","article-title":"Behavioral weight loss treatment in antipsychotic treated youth","volume":"4","author":"Nicol GE","year":"2016","unstructured":"Nicol GE, , Kolko RP, , Mills M, , Gunnarsdottir T, , Yingling MD, , Schweiger JA, , Lenze EJ, , Newcomer JW, , Wilfley D: Behavioral weight loss treatment in antipsychotic treated youth. Scand J Child Adolesc Psychiatry Psychol, 4:96\u2013104, 2016.","journal-title":"Scand J Child Adolesc Psychiatry Psychol"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201900089"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700107"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u202645.w3700"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0426-8"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/0706743718779950"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2017-006756"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0145"},{"key":"e_1_3_3_40_1","first-page":"218","article-title":"Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth","volume":"20","author":"Pringsheim T","year":"2011","unstructured":"Pringsheim T, , Panagiotopoulos C, , Davidson J, , Ho J, , Group CG: Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth. J Canad Acad Child Adolesc Psychiatry, 20:218\u2013233, 2011.","journal-title":"J Canad Acad Child Adolesc Psychiatry"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.0067"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0156"},{"key":"e_1_3_3_43_1","first-page":"1035","article-title":"Atypical antipsychotic-induced weight gain: Insights into mechanisms of action","volume":"25","author":"Roerig JL","year":"2011","unstructured":"Roerig JL, , Steffen KJ, , Mitchell JE: Atypical antipsychotic-induced weight gain: Insights into mechanisms of action. Central Nerv Syst Drugs, 25:1035\u20131059, 2011.","journal-title":"Central Nerv Syst Drugs"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371506001005"},{"key":"e_1_3_3_45_1","first-page":"134","article-title":"Barriers and facilitators to implementation of a metabolic monitoring protocol in hospital and community settings for second-generation antipsychotic-treated youth","volume":"20","author":"Ronsley R","year":"2011","unstructured":"Ronsley R, , Raghuram K, , Davidson J, , Panagiotopoulos C: Barriers and facilitators to implementation of a metabolic monitoring protocol in hospital and community settings for second-generation antipsychotic-treated youth. J Canad Acad Child Adolesc Psychiatry, 20:134\u2013141, 2011.","journal-title":"J Canad Acad Child Adolesc Psychiatry"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700504"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2012.18.9.676"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700547"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-475X.2004.04006.x"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006992"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/10398560801958549"},{"key":"e_1_3_3_52_1","unstructured":"Washington SN: Implementing Early Intervention Guidelines to Reduce Metabolic Syndrome in Adolescents Taking Second Generation Antipsychotics (SGA) in a Psychiatric Residential Setting. (10256474 D.N.P.) Brandman University Ann Arbor 2017."},{"key":"e_1_3_3_53_1","first-page":"302","article-title":"Health information preference among youth and caregivers related to second-generation antipsychotic treatment","volume":"21","author":"Xu Y","year":"2012","unstructured":"Xu Y, , Nguyen D, , Davidson J, , Panagiotopoulos C: Health information preference among youth and caregivers related to second-generation antipsychotic treatment. J Canad Acad Child Adolesc Psychiatry, 21:302\u2013309, 2012.","journal-title":"J Canad Acad Child Adolesc Psychiatry"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2020.0115","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2020.0115","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2020.0115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:55:57Z","timestamp":1777388157000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2020.0115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1089\/cap.2020.0115"],"URL":"https:\/\/doi.org\/10.1089\/cap.2020.0115","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}